侵袭性真菌性鼻窦炎上颌骨缺损的游离皮瓣重建结局
回顾性分析2010–2022年27例因侵袭性真菌性鼻窦炎行游离皮瓣重建的患者,7例(25.9%)出现伤口愈合延迟。末次清创至重建间隔短于2个月与伤口愈合延迟相关(Fisher精确检验 p=0.0062)。糖尿病、BMI、HbA1c及骨重建与愈合延迟无显著关联。
要点
- 侵袭性真菌性鼻窦炎上颌骨缺损可在抗真菌药物治疗下行游离皮瓣重建,结局良好。
- 末次清创后2个月内早期重建与伤口愈合延迟相关(p=0.0062)。
- 糖尿病、BMI、HbA1c及骨重建与伤口愈合延迟无显著关联。
核心结论
- 侵袭性真菌性鼻窦炎上颌骨缺损患者可在抗真菌药物治疗下接受游离皮瓣重建并获得良好结局。
- 末次清创后2个月内早期重建与伤口愈合延迟相关。
研究设计与样本
- 回顾性综述,纳入2010–2022年因侵袭性真菌性鼻窦炎行游离皮瓣重建的患者27例。
- 比较伤口愈合延迟组与无延迟组在年龄、BMI、糖化血红蛋白、清创次数及末次清创至重建间隔方面的差异。
主要发现
- 27例中3例因白血病免疫抑制,21例患糖尿病。
- 患者平均接受4次手术治疗侵袭性真菌性鼻窦炎。
- 末次清创至皮瓣重建的间隔为5.58个月(±5.5)。
- 7例皮瓣(25.9%)出现伤口愈合延迟。
- 末次清创至重建间隔短于2个月与伤口愈合延迟相关(Fisher精确检验 p=0.0062);糖尿病、BMI、HbA1c及骨重建与伤口愈合延迟无显著关联。
临床怎么用
- 作者结论指出,侵袭性真菌性鼻窦炎上颌骨缺损患者可在抗真菌药物治疗下接受游离皮瓣重建并获得良好结局;末次清创后2个月内早期重建与伤口愈合延迟相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Microvascular free tissue transfer is routinely used for reconstructing midface defects in patients with malignancy, however, studies regarding reconstructive outcomes in invasive fungal sinusitis (IFS) are lacking. We aim to describe outcomes of free flap reconstruction for IFS defects, determine the optimal time to perform reconstruction, and if anti-fungal medications or other risk factors of an immunocompromised patient population affect reconstructive outcomes. METHODS: Retrospective review of reconstruction for IFS (2010-2022). Age, BMI, hemoglobin A1c, number of surgical debridements, and interval from the last debridement to reconstruction were compared between patients with delayed wound healing versus those without. Predictor variables for delayed wound healing and the effect of time on free flap reconstruction were analyzed. RESULTS: Twenty-seven patients underwent free flap reconstruction for IFS. Three patients were immunocompromised from leukemia and 21 had diabetes mellitus (DM). Patients underwent an average of four surgical debridements for treatment of IFS. The interval from the last IFS debridement to flap reconstruction was 5.58 months (±5.5). Seven flaps (25.9%) had delayed wound healing. A shorter interval of less than 2 months between the last debridement for IFS and reconstructive free flap procedure was associated with delayed wound healing (Fisher Exact Test p = 0.0062). Other factors including DM, BMI, HgA1c, and bone reconstruction were not associated with delayed wound healing. CONCLUSION: Patients with maxillectomy defects from IFS can undergo microvascular-free flap reconstruction with good outcomes while on anti-fungal medication. Early reconstruction in the first 2 months after the last IFS debridement is associated with delayed wound healing. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:1642-1647, 2024.
引用
- Rao SM, Knott PD, Sweeny L, et al. Microvascular Free Flap Outcomes in Maxillectomy Defects from Invasive Fungal Sinusitis. Laryngoscope. 2023. PMID: 37772913. doi:10.1002/lary.31081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。